Prolonged chemotherapy impairs liver regeneration after portal vein occlusion - An audit of 26 patients

European Journal of Surgical Oncology

Volumn 36, Issue 4, 2010, Pages 358-364

  Sturesson, C ^a   Keussen, I ^a   Tranberg, K G ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chemotherapy; Liver; Portal vein embolisation; Regeneration

Indexed keywords

BEVACIZUMAB; CAPECITABINE; CETUXIMAB; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ADULT; AGED; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; BILE DUCT FISTULA; CANCER ADJUVANT THERAPY; CANCER SIZE; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; LIVER FAILURE; LIVER HYPERTROPHY; LIVER METASTASIS; LIVER PARENCHYMA; LIVER REGENERATION; LIVER RESECTION; LIVER WEIGHT; MALE; MEDICAL AUDIT; MULTIPLE CYCLE TREATMENT; PLEURA FLUID; PORTAL VEIN OBSTRUCTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT DURATION; TREATMENT OUTCOME; URINARY TRACT INFECTION; VEIN LIGATION;

ADULT; AGED; CHEMOTHERAPY, ADJUVANT; COLORECTAL NEOPLASMS; EMBOLIZATION, THERAPEUTIC; FEMALE; HUMANS; LIGATION; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PORTAL VEIN; TIME FACTORS; TREATMENT OUTCOME;

EID: 77949275733     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.12.001     Document Type: Article

References (30)

1. Shoup M., Gonen M., D'Angelica M., et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 7 (2003) 325-330
2. Madoff D.C., Abdalla E.K., and Vauthey J.-N. Portal vein embolization in preparation for major hepatic resection. Evolution of a new standard of care. J Vasc Interv Radiol 16 (2005) 779-790
3. Ribero D., Abdalla E.K., Madoff D.C., Donadon M., Loyer E.M., and Vauthey J.-N. Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome. Br J Surg 94 (2007) 1386-1394
4. Nordlinger B., Sorbye H., Collette L., et al. Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases. J Clin Oncol 25S (2007) LBA5
5. Tanaka K., Adam R., Shimada H., Azoulay D., Lévi F., and Bismuth H. Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver. Br J Surg 90 (2003) 963-969
6. Adam R., Delvart V., Pascal G., et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy. A model to predict long-term survival. Ann Surg 240 (2004) 644-657
7. Rubbia-Brandt L., Audard V., Sartoretti P., et al. Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer. Ann Oncol 15 (2004) 460-466
8. Karoui M., Penna C., Amin-Hashem M., et al. Influence of preoperative chemotherapy on the risk of major hepatectomy for colorectal liver metastases. Ann Surg 243 (2006) 1-7
9. Vauthey J.-N., Pawlik T.M., Ribero D., et al. Chemotherapy regimen predicts steatohepatitis and an increase in 90-day mortality after surgery for hepatic colorectal metastases. J Clin Oncol 24 (2006) 2065-2072
10. Azoulay D., Castaing D., Smail A., et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 231 (2000) 480-486
11. Goéré D., Farges O., Leporrier J., Sauvanet A., Vilgrain V., and Belghiti J. Chemotherapy does not impair hypertrophy of the left liver after right portal vein obstruction. J Gastrointest Surg 10 (2006) 366-370
12. Beal I.K., Anthony S., Papadopoulou A., et al. Portal vein embolisation prior to hepatic resection for colorectal liver metastases and the effect of periprocedure chemotherapy. Br J Radiol 79 (2006) 473-478
13. Tanaka Y., Nagasue N., Kanashima R., Inokuchi K., and Sirota A. Effect of doxorubicin on liver regeneration and host survival after two-thirds hepatectomy in rats. Cancer 49 (1982) 19-24
14. Therasse P., Arbuck S.G., Eisenhauer E.A., et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 92 (2000) 205-216
15. Balzan S., Belghiti J., Farges O., et al. The "50-50 criteria" on postoperative day 5. An accurate predictor of liver failure and death after hepatectomy. Ann Surg 242 (2005) 824-829
16. Tanaka K., Shimada H., Matsuo K., ueda M., Endo I., and Togo S. Remnant liver regeneration after two-stage hepatectomy for multiple bilobar colorectal metastases. Eur J Surg Oncol 33 (2007) 329-335
17. Giraudo G., Greget M., Oussoultzoglou E., Rosso E., Bachellier P., and Jaeck D. Preoperative contralateral portal vein embolization before major hepatic resection is a safe and efficient procedure: a large single institution experience. Surgery 143 (2008) 476-482
18. Covey A.M., Brown K.T., Jarnagin W.R., et al. Combined portal vein embolization and neoadjuvant chemotherapy as a treatment strategy for resectable hepatic colorectal metastases. Ann Surg 247 (2008) 451-455
19. Bouzari H., Amisano M., Zorzi D., Vigano L., Capussotti L., and Muratore A. Hypertrophy of the future liver remnant volume following portal vein occlusion. Portal vein embolization vs portal ligation. HPB 8 S2 (2006) 27-28
20. Aussilhou B., Lesurtel M., Sauvanet A., et al. Right portal vein ligation is as efficient as portal embolization to induce hypertrophy of the left liver remnant. J Gastrointest Surg 12 (2008) 297-303
21. Broering D.C., Hillert C., Krupski G., et al. Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant. J Gastrointest Surg 6 (2002) 905-913
22. Abdalla E.K., Denys A., Chevalier P., Nemr R.A., and Vauthey J.-N. Total and segmental liver volume variations: implications for liver surgery. Surgery 135 (2004) 404-410
23. Nagino M., Ando M., Kamiya J., Uesaka K., Sano T., and Nimura Y. Liver regeneration after major hepatectomy for biliary cancer. Br J Surg 88 (2001) 1084-1091
24. Imamura H., Shimada R., Kubota M., et al. Preoperative portal vein embolization: an audit of 84 patients. Hepatology 29 (1999) 1099-1105
25. Nanashima A., Sumida Y., Shibasaki S., et al. Parameters associated with changes in liver volume in patients undergoing portal vein embolization. J Surg Res 133 (2006) 95-101
26. Welsh F.K.S., Tilney H.S., Tekkis P.P., John T.G., and Rees M. Safe liver resection following chemotherapy for colorectal metastases is a matter of timing. Br J Cancer 96 (2007) 1037-1042
27. Capussotti L., Muratore A., Ferrero A., Anselmetti G.C., Corgnier A., and Regge D. Extension of right portal vein embolization to segment IV portal branches. Arch Surg 140 (2005) 1100-1103
28. Covey A.M., Tuorto S., Brody L.A., et al. Safety and efficacy of preoperative portal vein embolization with polyvinyl alcohol in 58 patients with liver metastases. Am J Roentgenol 185 (2005) 1620-1626
29. Madoff D.C., Abdalla E.K., Gupta S., et al. Transhepatic ipsilateral right portal vein embolization extended to segment IV: improving hypertrophy and resection outcomes with spherical particles and coils. J Vasc Interv Radiol 16 (2005) 215-225
30. Dagher I., lainas P., Boudechiche L., et al. L'embolisation portale réversible induit une régénération hépatique efficace. Ann Chir 131 (2006) 665